Breast cancer risk in women with PALB2 mutations in different populations

Lancet Oncol. 2015 Aug;16(8):e375-6. doi: 10.1016/S1470-2045(15)00002-9.

Authors

Antonis C Antoniou¹, William D Foulkes², Marc Tischkowitz³; PALB2 Interest Group

Affiliations

¹ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
² Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada.
³ Department of Medical Genetics, University of Cambridge, Cambridge, UK. Electronic address: [email protected].

PMID: 26248842
DOI: 10.1016/S1470-2045(15)00002-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms / genetics*
Female
Genetic Predisposition to Disease*
Humans
Nuclear Proteins / genetics*
Tumor Suppressor Proteins / genetics*

Substances

Nuclear Proteins
Tumor Suppressor Proteins

Grants and funding

11174/CRUK_/Cancer Research UK/United Kingdom